Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary

Cristiana Sessa, Cristina Bonazzi, Fabio Landoni, Sergio Pecorelli, Enrico Sartori, Costantino Mangioni

Research output: Contribution to journalArticle

Abstract

The combination of cisplatin, vinblastine, and bleomycin was administered to 13 previously untreated patients with pure endodermal sinus tumor of the ovary. Twelve had unilateral salpingo-oophorectomy as initial surgery. Among 11 women whose alpha-fetoprotein (AFP) levels returned to normal after cisplatin, vinblastine, and bleomycin therapy, nine are alive with no evidence of disease after periods of 20 months to six years and two months. In two patients, AFP levels returned to normal only after the introduction of different combination chemotherapies. Hematologic toxicity was moderate. Pulmonary toxicity due to bleomycin occurred in two cases. All menstruating patients resumed normal menstrual function after the interruption of chemotherapy. Two patients delivered normal term infants.

Original languageEnglish
Pages (from-to)220-224
Number of pages5
JournalObstetrics and Gynecology
Volume70
Issue number2
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary'. Together they form a unique fingerprint.

  • Cite this

    Sessa, C., Bonazzi, C., Landoni, F., Pecorelli, S., Sartori, E., & Mangioni, C. (1987). Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary. Obstetrics and Gynecology, 70(2), 220-224.